Results 251 to 260 of about 701,149 (346)
Antitubercular evaluation of a novel library of isoniazid‐dihydropyrimidinone molecular hybrids (8a–8n) discloses a potent compound with MIC = 0.39μg mL−1 against M. tuberculosis mc26230. Cytotoxicity, stability, and in silico studies, including molecular docking and ADME/T (absorption, distribution, metabolism, excretion, and toxicity) analysis ...
Gobind Kumar+10 more
wiley +1 more source
Differences in the Clinicopathologic and Radiological Characteristics of Patients With Microcystic and Macrocystic Serous Cystadenoma of the Pancreas. [PDF]
Lu X+11 more
europepmc +1 more source
Green’s function for the five-dimensional SU(2) MIC–Kepler problem [PDF]
Mikhail Pletyukhov, E. A. Tolkachev
openalex +1 more source
Targeting ATP synthase in Gram‐negative pathogens. Presented is the first disclosure of quinoline‐derived antibiotics inhibiting multidrug resistant Acinetobacter baumannii ATP synthase and expansion of the structure activity relationship profile of Pseudomonas aeruginosa ATP synthase inhibitors.
Katie T. Ward+9 more
wiley +1 more source
Trends of Colistin MIC Among <i>Acinetobacter Baumannii</i> and <i>Pseudomonas aeruginosa</i> at a First-Class Hospital in Vietnam. [PDF]
Nguyen THN+6 more
europepmc +1 more source
Is Mycobacterial InhA a Suitable Target for Rational Drug Design?
InhA is the target of isoniazid, a first‐line antituberculosis drug. Isoniazid is, in fact, a prodrug that needs to be activated. Researchers are trying to develop direct inhibitors of InhA. This includes the resolution of crystallographic structures. The Protein Data Bank contains over a hundred InhA structures.
Julien Rizet+7 more
wiley +1 more source
Healthcare-associated bloodstream infections caused by bacterial and fungal contamination of intravenous fluids and medicines in healthcare facilities in low- and middle-income countries: a scoping review. [PDF]
Nyandwaro J+3 more
europepmc +1 more source
Quinazolinone derivatives have emerged as promising scaffolds in antimicrobial drug discovery. This work focuses on the design, synthesis, and evaluation of novel quinazolinone‐based compounds and predicts their potential to interact with mycobacterial penicillin‐binding proteins (PBPs).
MAREK KERDA+15 more
wiley +1 more source